Aileron Therapeutics, Inc. (ALRN), a biopharma company, Tuesday announced the stepping down of Chief Executive Officer, Manuel Aivado.
He will be replaced by current Chief Operating Officer and President Brian Windsor, effective March 11.
Prior to joining Aileron, Windsor was the chief executive of Lung. He was also the Chief Science Officer and Director of TFF Pharmaceuticals, Inc.
In pre-market activity, Aileron Therapeutics shares are trading at $5.50, down 1.43% on the Nasdaq.
For comments and feedback contact: editorial@rttnews.com
Business News
June 05, 2026 16:18 ET A busy week for economic news flow saw a slew of reports being released that reflected the trends in the U.S. labor market. In Europe, economic growth and inflation data gained attention as the European Central Bank and Bank of England head for policy session later in the month. In Asia, the monetary policy session of the Indian central bank was in focus as the country, a major oil importer, reels under the pressures of a weaker rupee and rising inflation.